Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma

Published:2017-11-14 Issue:1 Volume:48 Page:52-60
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Yamanaka Chihiro¹,Wada Hiroshi¹,Eguchi Hidetoshi¹,Hatano Hisanori¹,Gotoh Kunihito¹,Noda Takehiro¹,Yamada Daisaku¹,Asaoka Tadafumi¹,Kawamoto Koichi¹,Nagano Hiroaki¹,Doki Yuichiro¹,Mori Masaki¹

Affiliation:

1. Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

Funder

JSPS KAKENHI

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/1/52/25535474/hyx157.pdf

Reference41 articles.

1. Prognostic prediction and treatment strategy in hepatocellular carcinoma;Bruix;Hepatology,2002

2. Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma;Tomimaru;Surg Today,2015

3. The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma;Okamura;Surg Today,2015

4. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

5. Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B;Hammad;Surg Today,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids;Biochemical and Biophysical Research Communications;2024-05

2. Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids;2024-01-31

3. An overview of hepatocellular carcinoma stem cells and potential targeted therapies;Cancer Stem Cells and Signaling Pathways;2024

4. Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics;International Review of Cell and Molecular Biology;2024

5. Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability;Clinical Epigenetics;2023-11-08